Overview
SGD Pharma is a global leader in glass pharmaceutical packaging, specializing in molded and tubular glass for primary packaging of parenteral, oral, and nasal products. With over a century of expertise since 1896, the company operates five ISO 15378 certified, GMP-compliant manufacturing plants worldwide. Their offerings include innovative solutions like the Sealian platform and Proseal+ external treatment technology, complemented by partnerships with industry leaders like Corning for advanced vial technologies.
Frequently asked questions
- What types of pharmaceutical glass packaging does SGD Pharma produce?
- SGD Pharma specializes in molded and tubular glass for primary pharmaceutical packaging, including vials, ampoules, and custom solutions for parenteral, oral, and nasal drug delivery applications.
- What quality and regulatory certifications does SGD Pharma maintain?
- SGD Pharma operates five ISO 15378 certified, GMP-compliant manufacturing plants that ensure reliable global supply chain compliance and meet stringent pharmaceutical packaging standards.
- What innovative technologies does SGD Pharma offer?
- SGD Pharma offers the Sealian platform for enhanced packaging performance, Proseal+ external treatment for improved moisture and oxygen protection, siliconized glass vial options, and access to Corning's Velocity Vial technology through their joint venture in India.
- Where does SGD Pharma manufacture its products?
- SGD Pharma operates manufacturing facilities globally, including a state-of-the-art center of excellence in Saint-Quentin Lamotte, France, and a joint venture facility in Telangana, India, with pharmaceutical tubing production expected to begin in 2025.
- What additional services does SGD Pharma provide beyond glass packaging?
- Beyond primary glass packaging, SGD Pharma offers packaging equipment, siliconization services, and specialized treatments to enhance vial performance and extend pharmaceutical product shelf life.